The University of Cambridge Metabolic Research Laboratories and its embedded MRC Metabolic Diseases Unit investigate the mechanisms through which metabolic health is maintained and how this is disturbed in disease.
We seek to use that knowledge to aid better treatment and prevention of obesity, Type 2 diabetes and related endocrine and metabolic diseases.
MRL groups encompass skills in genetics, cell biology, cell signalling, neuroendocrinology, bioenergetics, human and animal physiology, experimental medicine and clinical trials.
The MRL is the base for the MRC Metabolic Diseases Unit which supports four programmes of research that aim to improve understanding of the mechanisms responsible for obesity and related metabolic diseases.
Together with a Welcome Strategic Award, it also supports core scientific facilities that underpin basic and experimental science at the MRL.
Latest News
SLC26A7 mutations cause goitrous congenital hypothyroidism
In a study published in JCI Insight, Nadia Schoenmakers and colleagues first describe homozygous truncating mutations in an anion transporter…
Directors Collaborative Awards for MRL post-doctoral researchers Fund and purpose Up to £10,000 will be available each year (2018-2023) from…
A study published today in Cell Reports suggests that a large mixed-meal tolerance test may detect individuals with metabolic disease…
Getting blood glucose sorted while in hospital: the role of the artificial pancreas
A new study, led by Prof Roman Hovorka and published today in the New England Journal of Medicine, shows that an ‘artificial…
